all claims made for cosmetic products, regardless of where they appear (e.g. on pack, online, on social media posts, on advertorials, on influencers posts, etc.) or the format (text, images, symbols, etc.), must comply with Article 20 of the CPR and the Common Criteria for Cosmetic Claims.
The Responsible Person placing cosmetic products on the market is responsible for any claims made, including their wording and has the burden of proof for the appropriate claim substantiation.

Products intended to treat or prevent eczema, psoriasis, dermatitis or other adverse skin conditions will be considered to be medicinal products. This factsheet provides the specific phrases agreed with the MHRA when referring to eczema on cosmetic products.

This CTPA guide has been created to help advertisers understand more clearly the framework in which cosmetic claims appear and the way in which cosmetic claims may be classified.

The Guide is split into three sections: Framework of Common Understanding, Building Blocks of Claim Support, Practical Guide to Good Study Design. Key new features of the 2018 edition are: updated references (MHRA Guidance Note 8, Cosmets Regulation, Common Criteria on Cosmetic Claims, Technical Documnt on Cosmetic Claims, CAP Note on the Use of Post-production Technique, ISO 16128); focus on the role of the Responsible Person; updated views of the Committee of Advertising Practice (CAP), Advertising Standards Authority (ASA) and Clearcast; decision tree and case studies for practical understanding.

The Guide is endorsed by CAP, ASA and Clearcast.

This guide covers claims relating to adverse skin conditions including eczema, psoriasis, dermatitis, rosacea, acne and spots.

This Help Note on 'Free from' claims has been created to help non-member companies understand the European Commission's Technical Document on cosmetic claims. The Help Note reviews how the Common Criteria for cosmetic claims also apply to 'free from' claims.

In collaboration with the Medicines and Healthcare products Regulatory Agency (MHRA), CTPA has created a guide on common understanding of the cosmetic/medicine borderline for toothpaste claims. The objective of this guidance is to set a common understanding on the types of claims made for toothpastes and what this means in terms of the regulations that will apply to individual products in light of those claims.

This booklet is an easy reference guide on the regulatory framework for cosmetic claims.

We are seeing a growth of alarmist stories where consumers are being given confusing information implying that we are constantly exposed to cancer causing chemicals in our everyday lives. It is crucial that we see risks such as these in perspective. We are committed to dispelling myths and assumptions that all chemicals are dangerous to our health. We believe that tackling the debate around risk and risk communication is essential to avoid a future where people live in fear of safe everyday products.

Our industry faces the challenge to put risk into perspective and demonstrate the difference between risk and hazard. In this paper we argue that consumers deserve more credit for holding sensible attitudes to risk. It challenges perceptions, often created by NGOs and the media, of a society frightened of the results of scientific developments and scared of everyday products. What is clear from this research is that when given information in a balanced way, consumers understand the benefits of scientific progress and also appreciate that zero risk in life is impossible.

This guide has been produced to help explain what to do if you experience a reaction to a cosmetic product and why it is important to inform the product manufacturer.

This booklet contains facts and information to help dispel the myths and misinformation that can circulate and cause alarm and worry for the millions of consumers who use cosmetic products every day.

This report argues that building self-esteem will lead to a more productive workforce in the UK and should be an essential part of social and economic policy. As the job for life has disappeared, the need for high levels of self-esteem has increased to deal with what is considered to be a riskier world of work. In turn, self-esteem underpins a greater desire for new skills through training in order to succeed in the workplace.

According to this research by independent think tank Demos, commissioned by the CTPA, self-esteem is the lifeline for modern living and lies at the heart of successful, modern societies.The report argues that self-esteem is more important today than ever before. It explains that we lead increasingly open-ended lives, with fewer universal values, where people are responsible for creating their own individuality. However, we live in a society of high aspirations where our self-confidence is regularly tested as we struggle to meet the standards we create for ourselves.

Auditing is a critical improvement tool and can be used to determine whether: the quality assurance system is operating effectively; products are consistently manufactured to meet their specifications; procedures are followed and records are kept. This document covers all major aspects of GMP and can be used as a means of improving internal standards and assessing external contractors and vendors.

Microbiologists can be inundated with literature advertising equipment and courses relating to 'Rapid Microbiological Methods' and 'Alternative Microbiological Methods'. Often, however, the literature does not explain whether the method will work for the company's product range, whether it is cost effective, how it should be validated, how any changes to microbiological risk are managed and if the purchase can be justified. Intended for microbiologists this guide looks at how to make a method become a reality, possible applications and the considerations recommended when researching rapid and alternative methods. Included in the guide is a comparison table that provides a summary of the suitable applications and any relevant advantages and disadvantages for each method.

This guide is published jointly with Pharmig.

This CTPA document 'GMP - A Practical Guide for the Cosmetic Industry 2015' comprises the accumulated hands-on knowledge of some of the most experienced GMP specialists, Quality Assurance Managers, Quality Systems Managers and Microbiologists in our industry. The document deals with essential systems and procedures that should be in place to ensure the effective implementation of GMP and covers the critical stages of GMP implementation throughout the design, development and production process to the final customer/consumer. This 2015 revision will be particularly useful to companies who are looking for assistance on how to achieve the level of compliance outlined in ISO 22716.

All members of any CTPA committee are expected to act at all times within the requirements of the laws
surrounding competitive and anti-competitive behaviour. This requirement is active for all the time guests are present on CTPA premises and not just when a committee meeting is in session. This guideline provides information for committee members when attending CTPA meetings, including the CTPA privacy policy.

This document offers guidance to CTPA members and staff on their conduct whilst in CTPA meetings whether in CTPA offices or externally within the context of EC and national competition law.

The Guide, which was published in 1996 and updated in 2019, provides;

- a specification for cosmetic talc to ensure the virtual absence of potentially harmful contaminants, and;
- updated guidance to members on talc sourcing, treating and handling.

In the 2019 update, further clarification on the information about amphiboles and asbestos has been provided, particularly in the context of the latest methods of analysis and levels of detection.

This position paper provides information on the UK relevant regulatory frameworks for cosmetics containing cannabis and cannabis extracts.

This guideline outlines the specific obligations for distributors established under Article 6 of the EU Cosmetics Regulation and clarifies the aspects for which a distributor is not responsible.

This guide has been written in clear everyday language to help explain, to SMEs in particular, the obligations of cosmetic companies under the EU Cosmetics Regulation 1223/2009.

Sun protection products are an important part of a sunsafe regime. They need to be applied generously and it is recommended that they should be re-applied frequently to maintain the protection. However, in certain circumstances, frequent reapplication can be difficult. For example, when participating in outdoor sports or working outdoors.

Durable sunscreens (sometimes referred to as 'extended wear' or 'once a day' products) have been formulated to stay on the skin longer while maintaining their level of sun protection.

The CTPA Sun Products Working Group has created a guide which provides some key considerations that should be taken into account when manufacturing durable sunscreen products.

CTPA has created a "Guideline on Artificially Enhanced Nails and Minimising the Risk of Allergy", which has been developed for salon professionals, consumers, manufacturers and others with involvement in artificially enhanced nails. The Guideline explains that dermatologists are seeing an increase in the rates of allergic reaction to acrylate monomers in Liquid and Powder (L&P) and UV cured gel nail systems, and contains advice on how to minimise the risk of developing such an allergy.

The Guideline contains advice for safe use of these products for both salon professionals and end users, highlighting the following key points:

- Avoid skin contact
- Apply to healthy nails only
- Wear appropriate gloves
- Do no reuse gloves
- Remove gloves in a manner which avoids skin contact with the contaminated part of the gloves
- Use the correctly-matched lamp and gel system
- Use reputable products which comply with cosmetics legislation

In order to improve the communication and engagement between dermatologists and companies, CTPA has developed a guidance document: 'Patch Test Guidelines'. It has been developed in conjunction with dermatologists from the British Society for Cutaneous Allergy (BSCA). If it is appropriate to send product or ingredient samples, the guideline explains how this should be done. The following topics are covered:

- how and why a company may be contacted by a dermatologist;
- the information that should be exchanged between the company and the dermatologist;
- the type of materials that should and should not be provided from a company to a dermatologist;
- how companies prepare and provide these samples.

All cosmetic products sold in the European Union (EU) must display a complete ingredients list. In whatever European country you buy your cosmetic product, the ingredient names will be the same.

This help note has been created to explain the way that cosmetics are ingredient labelled and includes examples of ingredient names as they appear on the label.

Finished cosmetic products are exempt from the legislation requiring the provision of a 16-point Safety Data Sheet (SDS), sometimes referred to as Material Safety Data Sheets (MSDS). However, it must be recognised that there are legal requirements under Health and Safety legislation to provide a certain amount of information for some products regarding transport and safe handling.

This Information Note explains the legal requirements and provides examples of how information may be provided to distributors, retail outlets, beauty salons etc.